RECURSION PHARMACEUTICALS INC has a total of 16 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets computer technology, measurement and pharmaceuticals are ACCELRYS INC, GUANGZHOU DAAN CENTER FOR CLINICAL LABORATORY CO LTD and ACUITY IMAGING LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Victors Mason | 7 |
#2 | St-Jean-Leblanc Cedric | 6 |
#3 | Victors Mason L | 6 |
#4 | Borgeson Blake C | 6 |
#5 | Borgeson Blake | 6 |
#6 | Quigley Ian | 4 |
#7 | Gibson Chris | 2 |
#8 | Considine Timothy | 2 |
#9 | Healey David | 2 |
#10 | Goossens Emery | 2 |
Publication | Filing date | Title |
---|---|---|
US2021071256A1 | Systems and methods for pairwise inference of drug-gene interaction networks | |
WO2020257501A1 | Systems and methods for evaluating query perturbations | |
WO2020190585A1 | Process control in cell based assays | |
US10743109B1 | Ordered picklist for liquid transfer | |
WO2019178322A1 | Methods of treating hereditary hemorrhagic telangiectasia and related diseases and methods related thereto | |
US2020152295A1 | Systems and methods for high throughput compound library creation | |
US10146914B1 | Systems and methods for evaluating whether perturbations discriminate an on target effect | |
WO2018112409A1 | Methods of treating ataxia-telangiectasia |